SARS-CoV-2 infections after Pfizer-BioNTech BNT162b2 vaccination in routinely screened workforce

0

What The Study Did: This study describes an association between the Pfizer-BioNTech BNT162b2 vaccine and decreased risk of symptomatic and asymptomatic infections with SARS-CoV-2 in hospital employees.

Authors: Li Tang, Ph.D., of the St. Jude Children’s Research Hospital in Memphis, Tennessee, is the corresponding author.

To access the embargoed study: Visit our For The Media website at this link https://media.jamanetwork.com/

(doi:10.1001/jama.2021.6564)

Editor’s Note: The article includes conflict of interest and funding/support disclosures. Please see the article for additional information, including other authors, author contributions and affiliations, conflict of interest and financial disclosures, and funding and support.

###

Media advisory: The full study is linked to this news release.

Embed this link to provide your readers free access to the full-text article This link will be live at the embargo time https://jamanetwork.com/journals/jama/fullarticle/10.1001/jama.2021.6564?guestAccessKey=f83a0246-d935-4e27-ae7d-84249041c86a&utm_source=For_The_Media&utm_medium=referral&utm_campaign=ftm_links&utm_content=tfl&utm_term=050621

Media Contact
JAMA Network Media Relations

[email protected]

Leave A Reply

Your email address will not be published.